$IMMB .213 Immunotech Laboratories Inc. Announces

New Post Public Reply Private Reply Replies (1) Message Board
jstops mrchipper #20881

[b]$IMMB[/b] .213 Immunotech Laboratories Inc. Announces Clinical Trials Updates For Company's AIDS-HIV "IPF" Medicines


PASADENA, Calif., [b][color=blue]Feb. 20, 2013[/color][/b] /PRNewswire via COMTEX/ -- Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) Today announced the following updates for the International Clinical Trials of the company's patented AIDS-HIV "IPF" Medicine(s).

Immunotech Founder and President Harry Zhabilov today announced the progress with the project IPF-ITV-1 in the European Union. Mr. Zhabilov stated: "We have negotiated with two of the biggest hospitals in Bulgaria (thus, European Union) to carry our clinical trials of IPF-ITV-1 and ITV-2 as follows:


At the Infectious Disease Hospital, Sofia, with Hospital Director Prof. Cherveniakova we will carry out clinical trials of ITV-1 with 50 patients infected with HIV-AIDS in its most advanced stage.


At the Military Hospital, Sofia, with Hospital Director Prof. General Stoyan Tonev we will carry out clinical trials of ITV-2 with 50 patients ill with chronic hepatitis in its most advanced stage." The clinical trials will be conducted parallel with protease inhibitor.


Mr. Zhabilov further stated: "We believe that in both cases, the results will be very good, because in Bulgaria until this point, we have already applied the experimental labeled "IPF" Medicine with HIV infected volunteers and the outcomes to date have been extremely successful."


Immunotech recently completed negotiations in the Republic of Macedonia with Bionika Pharmaceuticals who agreed to carry out clinical trials of IPF-ITV-3 with 50 patients ill with HCV using the "IPF" labeled Experimental Drug Medicines.


The clinical trials in Bulgaria (Referred to as, EU) are scheduled to begin in March 2013 and end in August 2013, which will give Immunotech, the rights to receive approval for huge applications of the "IPF" Medicines. In this respect, Immunotech has had a series of conversations with Mr. Vladimir Stoichev, the Deputy General Director from Sopharma Bulgaria, and the parties have reached agreement for the signing of a contract between Immunotech Laboratories BG and Sopharma for joint production of IPF-ITV.


Sopharma is a leading pharmaceutical company in the European Union.


RELEVANT ARTICLES & LINKS FOR AIDS-HIV MEDICINES


http://news.yahoo.com/gsk-wins-priority-statu...nance.html


About Immunotech Laboratories Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and Aids. www.immunotechlab.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cathy Craig Drives $163M in Broken Bow Airbnb Deals

Updated Category News Views 0

Investors Find Gold in Broken Bow’s Airbnb Market When did Broken Bow, Oklahoma, become the go-to spot for adventurous investors looking to park their cash in timberland sanctuary cabins? Well, Cathy Craig seems to know the secret sauce, having navigated over $163 million worth of Airbnb and VRBO cabin deals for her clients since 2021. Her knack for spotting cabins that...

Continue Reading
Endava Facing Securities Fraud Suit; Stocks Down 24%

Updated Category News Views 99

Endava Hits Rough Patch with Legal Battle Brewing So here we are, watching Endava plc struggle through legal quagmires and tumbling stock prices. Come September 21, 2026, news hit the street: Endava's CFO, Mark Thurston, found himself on administrative leave due to an investigation surrounding some shaky accounting practices. The Audit Committee raised a red flag, and...

Continue Reading
Alair Homes Expands Footprint in Missouri, Partnering with Local Talent

Updated Category News Views 54

Well, here's a move that might not have every trader jumping up, but it sure rings a few bells for those watching the construction sector. Alair Homes, the giant in the custom building space, is planting roots in Columbia, Missouri, by joining forces with Brad Young, the brain behind TigerTown Home Improvement. Now, that's one way to bolster your game in a growing market...

Continue Reading
Smart Ports: Riding the High Seas of Innovation

Updated Category News Views 0

A Deep Dive into Smart Ports The old days of maritime operations are long gone. We're now staring at the future of port operations with these so-called 'smart ports.' The smart port market is bracing to skyrocket, with the valuation expected to leap from USD 4.2 billion in 2026 to a whoppin' USD 23.10 billion by 2034. That’s a galloping CAGR of 23.80%! Investors better...

Continue Reading
Greenworks Giveaway Powers Lawn Pros with $34K in Gear

Updated Category News Views 55

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Leadership Shifts in AAOMS: Dr. Crago at Helm

Updated Category News Views 27

New Guard at AAOMS: Dr. Crago Takes Charge With a blend of experience and a fresh theme, Dr. Charles A. Crago steps into the presidential shoes of the American Association of Oral and Maxillofacial Surgeons (AAOMS) for the 2026-27 term. Frankly, navigating leadership isn't new to Crago. I mean, after serving a lifetime in varied roles—President-Elect, Vice President,...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 40

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
Navigating New Home Builds: Tucson’s Precise Timelines

Updated Category News Views 78

Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 132

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Solutions and Investment Strategies from Aiden Labs

Updated Category News Views 502

Transforming Investment Strategies with Aiden Labs Aiden Labs is paving the way for the future of cryptocurrency investments through its innovative platform that seamlessly integrates artificial intelligence (AI) with decentralized finance (DeFi) solutions. The introduction of the DeFAI-agent marks a significant milestone, as it redefines the investment landscape by...

Continue Reading
Class Action Lawsuit Filed Against Five Below, Inc. (NASDAQ: FIVE)

Updated Category News Views 97

Class Action Lawsuit Filed Against Five Below, Inc. Pomerantz LLP has launched a class action lawsuit against Five Below, Inc. (NASDAQ: FIVE), addressing serious allegations of securities fraud and potentially illegal business practices involving the company and certain executives. This announcement has generated considerable interest among investors and shareholders...

Continue Reading
Terry Dunlap Joins NetRise to Elevate Cybersecurity Strategy

Updated Category News Views 170

Terry Dunlap Joins NetRise to Strengthen Cybersecurity Strategy Terry Dunlap, a highly regarded expert in the cybersecurity field, is stepping into a key position at NetRise as the Senior Vice President of Corporate Strategy and Development. In this innovative role, Dunlap will lead the company through its next major growth phase, with a focus on addressing the...

Continue Reading
Historic Treaty Settlement for Kiashke Zaaging Anishinaabek

Updated Category News Views 391

Kiashke Zaaging Anishinaabek and Canada Reach a Landmark Agreement Honouring treaty relationships is crucial in furthering reconciliation and rebuilding trust between Indigenous communities and the Canadian government. Recently, Chief Wilfred King of Kiashke Zaaging Anishinaabek announced a significant agreement alongside Minister Gary Anandasangaree, responsible for...

Continue Reading
YieldMax™ ETFs Unveils Latest Distribution Details for Investors

Updated Category News Views 789

Recent Distribution Announcements from YieldMax™ ETFs YieldMax™ is making waves in the investment world with its recent announcement regarding distributions for its lineup of ETFs. These distributions are essential for investors seeking to maximize their income streams through strategically managed funds. Overview of YieldMax™ ETFs YieldMax™ ETFs are designed to...

Continue Reading